Replies to post #397080 on Innovation Pharmaceuticals Inc (IPIX)

[TheHound]

If you want to speak about the Brilacidin ABSSSI trial you should not be afraid to tell the full story.

The full story - In the CEO’s own words…..

“The Company historically devoted most of its efforts and resources on drug development, regulatory matters, and clinical trials. Presently, the Company does not have sufficient financial resources to advance our drug candidates meaningfully.”

Result - the Brilacidin ABSSSI trial was a failure as is the company we invested in.

[Hungry_Ghost]

One dose of B426 was equivalent to a 7 day regimen of Daptomycin.
Think of the financial savings for insurance companies with a single dose cure.